Clinicodemographic Characteristics of COVID-19 Infection Among Patients with Rheumatic Diseases
Keywords:COVID-19 infection, rheumatic diseases, DMARDs, arthritis
Background: The occurrence of COVID-19 infection in rheumatic patients and their evaluation are of global interest. The purpose of this study was to determine the clinicodemographiccharacteristics of COVID-19 infection among rheumatic patients.
Methods: In this observational cross-sectional study, 167 consecutive patients of both genders from online consultancy were enrolled from 13th June to 12thOctober 2020 conducted in a tertiary level rheumatology consultation center, Modern One Stop Arthritis Care & Research Center®, Dhanmondi, Dhaka. The WHO case definition of COVID-19 and disease severity scoring tool were used for diagnosis and assessment of the patients.Suspected cases were interviewed in detail and investigated with RT-PCR for COVID-19, HRCT of the chest, X-ray chest P/A view, and other necessary tests. The prevalence of COVID-19 infection was expressed in percentage.
Results: Out of 167 rheumatic subjects,64 and 103 were men and women respectively, witha mean age of 42.15±13.04 years. The prevalence of COVID-19 infection was 7.78% (13/167). RT-PCR was positive in 9 (69.23%) patients and the remaining weresuspected cases (RT-PCR was negative but positive clinical features and X-ray chest findings.All COVID-19 positive patients presented with fever (100%).Among COVID-19 cases,spondyloarthritis (SpA), osteoarthritis of knee(OA),psoriatic arthrtis (PsA), rheumatoid arthritis (RA) and systemic lupus erythematosus(SLE)were5 (38.46%), 3 (23.08%), 2 (15.38%), 2 (15.38%) and 1 (7.69%) respectively.DMARDs/biologics wereongoingin 3 (tofacitinib), 1 (etanercept), 1 (methotrexate), 1 (sulphasalazine), 1(hydroxychloroquine) and 1 (leflunomide) patients.The use of non-specific drugs for Covid-19 treatment were azithromycin, ivermectin, doxycycline, and hydroxychloroquin. Among these rheumatic patients, the elderly group of patients with the comorbidities like diabetes5 (38.46%), hypertension 5 (38.46%)and bronchial asthma 3 (23.08%)were infected with COVID-19.
Conclusion: The prevalence of COVID-19 was 7.78% among the rheumatic patients. Fever was the universal presentation in this study. The commonest rheumatic diseases were SpA . Diabetes and hypertension werethe most common comorbidities in patients with rheumatic diseases with COVID-19 infection.
J Bangladesh Coll Phys Surg 2023; 41: 205-211
How to Cite
Submission of a manuscript for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted manuscripts become the permanent property of the Journal of Bangladesh College of Physicians and Surgeons and may not be reproduced by any means in whole or in part without the written consent of the publisher.
No part of the materials published in this journal may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher. Reprints of any article in the Journal will be available from the publisher.